老年人血压降低：甲基多巴的一项随机对照试验
Blood pressure reduction in elderly: a randomised controlled trial of methyldopa.
作者信息
Sprackling M E, Mitchell J R, Short A H, Watt G
出版信息
Br Med J (Clin Res Ed). 1981 Oct 31;283(6300):1151-3. doi: 10.1136/bmj.283.6300.1151.
Abstract
A total of 123 out of 549 elderly residents of local authority welfare homes in Nottinghamshire were found at screening to have a standing or lying diastolic blood pressure of 100 mm Hg or more. These 123 subjects were randomly allocated to simple observation or to treatment with methyldopa. The cumulative mortality was similar in the observed and treated groups and in the normotensive group from which the subjects had been separated. Thus moderate hypertension, whether treated or not, was not a major risk predictor in the elderly population studied.
摘要
在诺丁汉郡地方政府福利院的549名老年居民中，共有123人在筛查时被发现站立或卧位舒张压为100毫米汞柱或更高。这123名受试者被随机分配至单纯观察组或接受甲基多巴治疗组。观察组、治疗组以及从中分离出这些受试者的血压正常组的累积死亡率相似。因此，在本研究的老年人群中，中度高血压无论是否接受治疗，都不是主要的风险预测因素。
相似文献
1
Blood pressure reduction in elderly: a randomised controlled trial of methyldopa.老年人血压降低：甲基多巴的一项随机对照试验
Br Med J (Clin Res Ed). 1981 Oct 31;283(6300):1151-3. doi: 10.1136/bmj.283.6300.1151.
2
Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy.甲基多巴与氧烯洛尔治疗妊娠期高血压的随机对照比较研究。
Br Med J (Clin Res Ed). 1983 Jun 18;286(6382):1927-30. doi: 10.1136/bmj.286.6382.1927.
3
Methyldopa and propranolol or practolol in moderate hypertension.甲基多巴与普萘洛尔或心得宁用于中度高血压治疗
Br Med J. 1976 Jul 17;2(6028):137-9. doi: 10.1136/bmj.2.6028.137.
4
Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.酮色林治疗老年轻度至中度高血压：与甲基多巴的双盲对照研究
Clin Ther. 1989 May-Jun;11(3):363-72.
5
6
Comparison of oxprenolol vs methyldopa as second-line antihypertensive agents in the elderly.老年患者中氧烯洛尔与甲基多巴作为二线抗高血压药物的比较。
Arch Intern Med. 1988 Jan;148(1):77-80.
7
8
Atenolol, methyldopa, and chlorthalidone in moderate hypertension.阿替洛尔、甲基多巴和氯噻酮用于治疗中度高血压。
Br Med J. 1977 Jan 8;1(6053):76-8. doi: 10.1136/bmj.1.6053.76.
9
Comparison of indoramin and methyldopa in hypertension.吲哚拉明与甲基多巴治疗高血压的比较。
S Afr Med J. 1976 May 8;50(20):764-8.
10
[A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].美托洛尔与甲基多巴治疗高血压的比较评价（作者译）
G Ital Cardiol. 1980;10(11):1482-90.
引用本文的文献
1
Time to benefit for stroke reduction after blood pressure treatment in older adults: A meta-analysis.降压治疗对老年人卒中获益时间的荟萃分析。
J Am Geriatr Soc. 2022 May;70(5):1558-1568. doi: 10.1111/jgs.17684. Epub 2022 Feb 9.
2
Pharmacotherapy for hypertension in adults 60 years or older.60岁及以上成年人高血压的药物治疗
Cochrane Database Syst Rev. 2019 Jun 5;6(6):CD000028. doi: 10.1002/14651858.CD000028.pub3.
3
First-line drugs for hypertension.高血压一线用药。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD001841. doi: 10.1002/14651858.CD001841.pub3.
4
Pharmacotherapy for hypertension in adults aged 18 to 59 years.18至59岁成年人高血压的药物治疗
Cochrane Database Syst Rev. 2017 Aug 16;8(8):CD008276. doi: 10.1002/14651858.CD008276.pub2.
5
Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals.高血压患者预防心源性猝死的降压药物治疗
Cochrane Database Syst Rev. 2016 Mar 10;3(3):CD011745. doi: 10.1002/14651858.CD011745.pub2.
6
Are we using blood pressure-lowering drugs appropriately? Perhaps now is the time for a change.
J Hum Hypertens. 2014 Jan;28(1):68-70. doi: 10.1038/jhh.2013.79. Epub 2013 Aug 29.
7
Methyldopa for primary hypertension.甲基多巴用于原发性高血压。
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD003893. doi: 10.1002/14651858.CD003893.pub3.
8
Generalizability of guidelines and physicians' adherence. Case study on the Sixth Joint National Commitee's guidelines on hypertension.指南的可推广性及医生的依从性。关于第六届全国联合委员会高血压指南的案例研究。
BMC Public Health. 2003 Jul 21;3:24. doi: 10.1186/1471-2458-3-24.
9
Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trials.降压药物治疗及降低血压在结局试验中的益处。
J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):66-75. doi: 10.1111/j.1524-6175.2003.01307.x.
10
本文引用的文献
1
Failure of therapy to improve prognosis in elderly males with hypertension.治疗未能改善老年男性高血压患者的预后。
Med J Aust. 1980 Jul 12;2(1):27-31.
2
Hypertension in the elderly.老年人高血压
Arch Intern Med. 1980 Sep;140(9):1155-61.
3
Drug therapy: Management of hypertension in the elderly.药物治疗：老年人高血压的管理
N Engl J Med. 1980 Jun 19;302(25):1397-401. doi: 10.1056/NEJM198006193022505.
4
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.需要对每位患者进行长期观察的随机临床试验的设计与分析。II. 分析与示例。
Br J Cancer. 1977 Jan;35(1):1-39. doi: 10.1038/bjc.1977.1.
5
Arterial hypertension in old age.老年动脉高血压
Herz. 1978 Aug;3(4):235-44.
6
The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.β错误、II型错误以及样本量在随机对照试验设计与解读中的重要性。对71项“阴性”试验的调查。
N Engl J Med. 1978 Sep 28;299(13):690-4. doi: 10.1056/NEJM197809282991304.
7
Clinical management of venous thrombo-embolism.
Br Med Bull. 1978 May;34(2):169-75. doi: 10.1093/oxfordjournals.bmb.a071488.
8
Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly.
Lancet. 1978 Apr 1;1(8066):681-3. doi: 10.1016/s0140-6736(78)90797-3.
Zotero 插件